Cargando…
Can the Profitability of Medical Enterprises Be Improved After Joining China's Centralized Drug Procurement? A Difference-in-Difference Design
This paper explores the impact of joining centralized drug procurement of China on the profitability of medical enterprises by the difference-in-difference (DID) model. When centralized procurement cannot bring enough cost savings to enterprises, the price competition caused by centralized procureme...
Autores principales: | Hua, Yu-Fei, Lu, Jin, Bai, Bing, Zhao, Han-Qing |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8843945/ https://www.ncbi.nlm.nih.gov/pubmed/35178375 http://dx.doi.org/10.3389/fpubh.2021.809453 |
Ejemplares similares
-
Impact of China’s National Centralized Drug Procurement Policy on pharmaceutical enterprises’ financial performance: a quasi-natural experimental study
por: Sun, Zhixuan, et al.
Publicado: (2023) -
The impact of national centralized drug procurement on health expenditures for lung cancer inpatients: A difference-in-differences analysis in a large tertiary hospital in China
por: Zhang, Yuan-jin, et al.
Publicado: (2022) -
A European arena for joint innovation in healthcare: The Platform for Innovation of Procurement and Procurement of Innovation (PiPPi)
por: Andrews, Margaret R., et al.
Publicado: (2023) -
Does air quality improvement promote enterprise productivity increase? Based on the spatial spillover effect of 242 cities in China
por: Le, Dong, et al.
Publicado: (2022) -
Environmental Regulation, Environmental Decentralization, and Enterprise Environmental Protection Investment: Evidence From China
por: Liu, Li, et al.
Publicado: (2022)